SKI Market

A+| A| A-|

Indian Indices

Sensex

77,100.47 109.25
( 0.14%)

Global Indices

Nasdaq

51,823.54 -118.08
(-0.23%)

Dow Jones

7,358.68 -19.81
(-0.27%)

Hang Seng

69,065.93 -3,300.41
(-4.56%)

Nikkei 225

10,515.14 -14.75
(-0.14%)

Forex

USD-INR

94.41 -0.14
(-0.15%)

EUR-INR

107.28 -0.07
(-0.07%)

GBP-INR

124.48 -0.08
(-0.06%)

JPY-INR

0.58 0.00
(-0.20%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Parmax Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

540359

INE240T01014

-18.3323978

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

28.09

EPS(TTM)

Face Value()

Div & Yield %

Back

Standard Shoe Sole & Mould India reports standalone net loss of Rs 0.01 crore in the December 2025 quarter

Feb 14,2026

Net Loss of Standard Shoe Sole & Mould India reported to Rs 0.01 crore in the quarter ended December 2025 as against net loss of Rs 0.01 crore during the previous quarter ended December 2024. There were no Sales reported in the quarter ended December 2025 and during the previous quarter ended December 2024.

77,100.47 109.25 ( 0.14%)

51,823.54 -118.08 (-0.23%)

7,358.68 -19.81 (-0.27%)

69,065.93 -3,300.41 (-4.56%)

10,515.14 -14.75 (-0.14%)

94.41 -0.14 (-0.15%)

107.28 -0.07 (-0.07%)

124.48 -0.08 (-0.06%)

0.58 0.00 (-0.20%)